Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda

Go back to Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda
(NASDAQ: KROS) Delayed: 11.15 +0.50 (4.69%)
Previous Close $10.65    52 Week High
Open $10.74    52 Week Low
Day High $11.26    P/E N/A 
Day Low $10.58    EPS
Volume 319,631